<unk>  has mostly been studied in combination with an estrogen, so the side effects of<unk>  specifically or on its own have not been well-defined. Side effects associated with the combination of ethinylestradiol and<unk>  in premenopausal women, with greater than or equal to 2% incidence over up to 24 menstrual cycles, include headache/migraine (33%), abdominal/gastrointestinal pain (7.8%), vaginal infection (8.4%), vaginal discharge (6.8%), breast issues (including breast pain, discharge, and enlargement) (6.3%), mood disorders (including depression and mood alterations) (5.0%), flatulence (3.2%), nervousness (2.9%), and rash (2.6%). Side effects associated with the combination of estradiol and<unk>  in postmenopausal women, with greater than or equal to 5% incidence over one year, include headache (23%), upper respiratory tract infection (21%), breast pain (16%), back pain (12%), abdominal pain (12%), flu-like symptoms (11%), arthralgia (9%), vaginal bleeding (9%), dysmenorrhea (8%), sinusitis (8%), vaginitis (7%), pharyngitis (7%), fatigue (6%), pain (6%), nausea (6%), viral infection (6%), flatulence (5%), tooth disorder (5%), myalgia (5%), dizziness (5%), depression (5%), and coughing (5%).
Norgestimate
Nandrolone cyclohexylpropionate
Levonorgestrel
Ergometrine
Drostanolone propionate
Nandrolone furylpropionate
Etonogestrel
Norbormide